1. Brecher A. Mycosis fungoides. Dermatol Online J. 2003. 9:23.
Article
2. Kikuchi A, Naka W, Nishikawa T. Cutaneous T-cell lymphoma arising from parakeratosis variegata: long-term observation with monitoring of T-cell receptor gene rearrangements. Dermatology. 1995. 190:124–127.
Article
3. Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004. 18:397–415.
Article
4. Assaf C, Sterry W. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Cutaneous lymphoma. Fitzpatrick's dermatology in general medicine. 2008. 7th ed. New York, USA: McGraw-Hill;2154–2157.
5. Christine J. Elder DE, Elenitsas R, Johnson BL, Murphy GF, editors. Connective tissue disease. Lever's histopahology of the skin. 2005. 9th ed. Philadelphia, USA: Lippincott Williams & Wilkins;308–309.
6. McKee PH, Calonje E, Granter SR. Pathology of the skin with clinical correlations. 2005. 3rd ed. Philadelphia, USA: Elsevier Mosby;1763–1764.
7. Kreuter A, Hoffmamm K, Altmeyer P. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis. J Am Acad Dermatol. 2005. 52:706–708.
Article
8. Lee JB, Myung KB, Kim JH. Parapsoriasis variegata: report of a case. Korean J Dermatol. 1979. 17:367–371.
9. Jang HC, Ahn BJ, Kim SW, Kim DS. A case of poikilodermatous mycosis fungoides. Korean J Dermatol. 1999. 37:1515–1517.
10. Cho KH, Lee HS. A clinicopathological study of early mycosis fungoides. Korean J Dermatol. 1999. 37:838–845.
11. Lu D, Patel KA, Duvic M, Jones D. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol. 2002. 29:465–472.
Article
12. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999. 155:483–492.
Article
13. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990. 22:569–577.
Article
14. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Müller-Hermelink HK, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003. 97:610–627.
15. Nikolaou VA, Papadavid E, Katsambas A, Stratigos AJ, Marinos L, Anagnostou D, et al. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients. Br J Dermatol. 2009. 161:826–830.
Article
16. van Krieken JH, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007. 21:201–206.
Article
17. Thurber SE, Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol. 2007. 57:782–790.
Article
18. Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol. 2007. 156:1–10.
Article